PREDNISONE

PREDNISONE was reported 508025 times

PREDNISONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5708 0.7959
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 503 0.7530
2 SWOLLEN JOINT COUNT INCREASED 2394 0.7500
3 PEMPHIGUS 9293 0.7425
4 RHEUMATIC FEVER 3176 0.7118
5 RHEUMATOID FACTOR POSITIVE 3991 0.6902
6 LUPUS VULGARIS 865 0.6865
7 DUODENAL ULCER PERFORATION 4966 0.6671
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 1329 0.6635
9 C-REACTIVE PROTEIN 590 0.6365
10 HAND DEFORMITY 8069 0.6146
11 STEROID DEPENDENCE 523 0.5957
12 GRANULOMA SKIN 482 0.5871
13 FACET JOINT SYNDROME 1879 0.5766
14 BLOOD PRESSURE DIASTOLIC ABNORMAL 1438 0.5648
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1116 0.5381
16 BLOOD PRESSURE SYSTOLIC ABNORMAL 1302 0.5263
17 C-REACTIVE PROTEIN ABNORMAL 3287 0.5119
18 X-RAY ABNORMAL 909 0.5078
19 DUST ALLERGY 492 0.5015
20 SYNOVITIS 9040 0.5009
21 DISLOCATION OF VERTEBRA 1142 0.5002
22 HELICOBACTER INFECTION 5132 0.4988
23 MUSCLE INJURY 4135 0.4986
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3075 0.4730
25 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1003 0.4545
26 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1027 0.4454
27 FOLLICULITIS 4661 0.4440
28 RETINITIS 761 0.4401
29 PERICARDITIS 6862 0.4080
30 BLOOD PARATHYROID HORMONE DECREASED 583 0.3931
31 GLOSSODYNIA 8754 0.3906
32 HISTOPLASMOSIS DISSEMINATED 611 0.3848
33 PERIPHERAL VENOUS DISEASE 1513 0.3701
34 SECONDARY IMMUNODEFICIENCY 428 0.3523
35 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 826 0.3522
36 NOCARDIOSIS 896 0.3500
37 STEROID DIABETES 517 0.3444
38 BONE EROSION 1211 0.3421
39 DRUG TOLERANCE DECREASED 960 0.3415
40 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1711 0.3358
41 RHEUMATOID NODULE 925 0.3355
42 CONTRAINDICATED PRODUCT ADMINISTERED 10134 0.3344
43 SYSTEMIC LUPUS ERYTHEMATOSUS 11576 0.3258
44 FORCED EXPIRATORY VOLUME DECREASED 915 0.3226
45 STRONGYLOIDIASIS 521 0.3222
46 PULMONARY FUNCTION TEST ABNORMAL 487 0.3124
47 CRYPTOCOCCOSIS 501 0.3072
48 PANNICULITIS 733 0.3026
49 OBSTRUCTIVE AIRWAYS DISORDER 3363 0.3020
50 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 615 0.3013
51 WOUND 8095 0.2893
52 CUSHINGOID 879 0.2736
53 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2912 0.2629
54 CYTOMEGALOVIRUS VIRAEMIA 1165 0.2616
55 BRONCHIECTASIS 1729 0.2564
56 FULL BLOOD COUNT ABNORMAL 2699 0.2549
57 COMPLICATIONS OF TRANSPLANTED KIDNEY 564 0.2485
58 JOINT RANGE OF MOTION DECREASED 3299 0.2457
59 FAECAL CALPROTECTIN INCREASED 770 0.2429
60 BLOOD IMMUNOGLOBULIN E INCREASED 588 0.2426
61 KIDNEY TRANSPLANT REJECTION 1161 0.2417
62 GRIP STRENGTH DECREASED 2123 0.2410
63 MENINGITIS CRYPTOCOCCAL 418 0.2389
64 ASPERGILLUS INFECTION 1560 0.2374
65 IRRITABLE BOWEL SYNDROME 5052 0.2354
66 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3998 0.2352
67 THERAPEUTIC REACTION TIME DECREASED 684 0.2342
68 HISTOPLASMOSIS 410 0.2314
69 TENOSYNOVITIS 632 0.2289
70 CHRONIC SINUSITIS 857 0.2281
71 TRANSPLANT REJECTION 1823 0.2273
72 CYTOMEGALOVIRUS COLITIS 520 0.2259
73 HYPERCHOLESTEROLAEMIA 2141 0.2215
74 RHEUMATOID ARTHRITIS 25168 0.2214
75 BLOOD PRESSURE DIASTOLIC INCREASED 1018 0.2203
76 LIP DRY 1989 0.2188
77 SPUTUM DISCOLOURED 2063 0.2173
78 BURSITIS 2639 0.2173
79 BREAST CANCER STAGE III 1408 0.2172
80 ONYCHOMADESIS 911 0.2169
81 RHINITIS ALLERGIC 966 0.2168
82 BREATH SOUNDS ABNORMAL 1066 0.2160
83 DRUG LEVEL BELOW THERAPEUTIC 1192 0.2159
84 WOUND INFECTION 2348 0.2142
85 BLOOD PRESSURE DIASTOLIC DECREASED 1581 0.2140
86 WHEEZING 12542 0.2113
87 ARTHROPATHY 11718 0.2106
88 VARICELLA ZOSTER VIRUS INFECTION 437 0.2106
89 RESPIRATORY SYMPTOM 592 0.2079
90 NASAL POLYPS 1017 0.2063
91 FIBROMYALGIA 4982 0.2047
92 MUCORMYCOSIS 531 0.2042
93 ONYCHOMYCOSIS 880 0.2004
94 HEPATITIS B REACTIVATION 628 0.1977
95 DIFFUSE LARGE B-CELL LYMPHOMA 1517 0.1967
96 PNEUMOCYSTIS JIROVECII PNEUMONIA 1945 0.1935
97 BRAIN ABSCESS 487 0.1923
98 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9177 0.1909
99 BLOOD PRESSURE SYSTOLIC INCREASED 3719 0.1905
100 IMPAIRED HEALING 6240 0.1899
101 JUVENILE IDIOPATHIC ARTHRITIS 462 0.1887
102 BK VIRUS INFECTION 635 0.1881
103 AUTOIMMUNE DISORDER 1828 0.1874
104 EPSTEIN-BARR VIRUS INFECTION 1158 0.1852
105 POLYARTHRITIS 975 0.1848
106 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 607 0.1836
107 FINGER DEFORMITY 889 0.1833
108 INFUSION RELATED REACTION 12110 0.1825
109 LIVE BIRTH 1528 0.1825
110 THERAPEUTIC PRODUCT EFFECT DECREASED 8148 0.1817
111 PULMONARY FIBROSIS 3480 0.1812
112 POLYMYALGIA RHEUMATICA 565 0.1777
113 COLITIS ULCERATIVE 7705 0.1722
114 BRONCHOPULMONARY ASPERGILLOSIS 1320 0.1701
115 OBESITY 2661 0.1669
116 LOWER RESPIRATORY TRACT INFECTION 7559 0.1660
117 BLOOD PRESSURE FLUCTUATION 3981 0.1657
118 FOOT DEFORMITY 1798 0.1621
119 SCIATICA 2581 0.1617
120 ADENOVIRUS INFECTION 468 0.1612
121 MYCOBACTERIUM AVIUM COMPLEX INFECTION 432 0.1608
122 MUCOUS STOOLS 796 0.1605
123 PROCTITIS 449 0.1601
124 CHEST X-RAY ABNORMAL 490 0.1597
125 ASTHMA 17991 0.1590
126 PSORIATIC ARTHROPATHY 6387 0.1572
127 BLEPHAROSPASM 989 0.1569
128 CYTOMEGALOVIRUS INFECTION 2588 0.1556
129 C-REACTIVE PROTEIN INCREASED 5646 0.1550
130 NEPHROGENIC ANAEMIA 714 0.1540
131 SARCOIDOSIS 729 0.1533
132 LIVER INJURY 3714 0.1512
133 JOINT SWELLING 18162 0.1503
134 ANAL FISSURE 802 0.1494
135 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10626 0.1492
136 TYPE 2 DIABETES MELLITUS 4985 0.1479
137 KLEBSIELLA INFECTION 748 0.1478
138 ENTEROCOCCAL INFECTION 714 0.1476
139 EXOSTOSIS 1331 0.1456
140 BODY TEMPERATURE DECREASED 1430 0.1451
141 NAIL DISORDER 1265 0.1444
142 DRUG INTOLERANCE 13922 0.1440
143 SENSITIVITY TO WEATHER CHANGE 758 0.1439
144 EAR PRURITUS 505 0.1439
145 HYPOGAMMAGLOBULINAEMIA 931 0.1416
146 PSEUDOMONAS INFECTION 1214 0.1414
147 FREQUENT BOWEL MOVEMENTS 3813 0.1410
148 DRUG LEVEL ABOVE THERAPEUTIC 645 0.1407
149 DRUG LEVEL DECREASED 1432 0.1406
150 VASCULITIS 1635 0.1402
151 SWELLING 13119 0.1400
152 WALKING AID USER 924 0.1400
153 LUPUS-LIKE SYNDROME 1269 0.1398
154 ADRENAL INSUFFICIENCY 1694 0.1395
155 JOINT EFFUSION 959 0.1389
156 EOSINOPHIL COUNT INCREASED 1155 0.1385
157 HIP ARTHROPLASTY 2115 0.1380
158 HEPATIC ENZYME INCREASED 9406 0.1378
159 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1030 0.1371
160 POOR VENOUS ACCESS 1413 0.1364
161 DEFAECATION URGENCY 954 0.1360
162 INTENTIONAL PRODUCT USE ISSUE 11839 0.1350
163 TREATMENT FAILURE 11169 0.1347
164 SKIN NECROSIS 699 0.1346
165 BLOOD COUNT ABNORMAL 2035 0.1341
166 RALES 770 0.1325
167 CYTOMEGALOVIRUS INFECTION REACTIVATION 583 0.1318
168 OSTEOARTHRITIS 5560 0.1310
169 ARTHRITIS BACTERIAL 534 0.1300
170 DISCOMFORT 7936 0.1299
171 INFLAMMATION 6710 0.1299
172 PRODUCTIVE COUGH 6114 0.1279
173 OESOPHAGEAL CANDIDIASIS 504 0.1263
174 ESCHERICHIA INFECTION 1021 0.1240
175 UPPER-AIRWAY COUGH SYNDROME 1010 0.1225
176 PNEUMONIA FUNGAL 477 0.1208
177 PULMONARY FUNCTION TEST DECREASED 529 0.1207
178 OBSTRUCTION 482 0.1205
179 RHINOVIRUS INFECTION 469 0.1204
180 RED CELL DISTRIBUTION WIDTH INCREASED 500 0.1202
181 MUSCULOSKELETAL STIFFNESS 10531 0.1201
182 SYNOVIAL CYST 552 0.1194
183 THERAPY PARTIAL RESPONDER 1855 0.1188
184 PYODERMA GANGRENOSUM 425 0.1180
185 NIGHT SWEATS 3805 0.1180
186 APHTHOUS ULCER 915 0.1179
187 PULMONARY MASS 1740 0.1167
188 KNEE ARTHROPLASTY 2457 0.1166
189 SINUSITIS 11946 0.1164
190 MYASTHENIA GRAVIS 940 0.1163
191 MATERNAL EXPOSURE TIMING UNSPECIFIED 437 0.1162
192 CLOSTRIDIUM DIFFICILE COLITIS 1231 0.1160
193 BLISTER 6469 0.1151
194 OSTEOPOROSIS 4712 0.1144
195 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 937 0.1135
196 JOINT DISLOCATION 1201 0.1135
197 CLOSTRIDIUM DIFFICILE INFECTION 2459 0.1125
198 NODULE 1449 0.1109
199 BLOOD CHOLESTEROL INCREASED 5164 0.1107
200 LUNG DISORDER 5427 0.1106
201 GRAFT VERSUS HOST DISEASE 796 0.1106
202 COVID-19 PNEUMONIA 1303 0.1102
203 DRUG SPECIFIC ANTIBODY PRESENT 717 0.1101
204 ATELECTASIS 1061 0.1097
205 ESCHERICHIA URINARY TRACT INFECTION 466 0.1095
206 CANDIDA INFECTION 1850 0.1094
207 RESPIRATORY RATE INCREASED 967 0.1088
208 STOMATITIS 6593 0.1086
209 IMMUNOSUPPRESSION 952 0.1078
210 HERPES SIMPLEX 699 0.1074
211 ARTHRITIS INFECTIVE 498 0.1073
212 THERAPY NON-RESPONDER 4774 0.1061
213 SQUAMOUS CELL CARCINOMA OF SKIN 641 0.1061
214 MOBILITY DECREASED 7577 0.1054
215 LOWER LIMB FRACTURE 2017 0.1049
216 STAPHYLOCOCCAL BACTERAEMIA 456 0.1048
217 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1001 0.1048
218 RHINITIS 841 0.1042
219 EAR PAIN 2021 0.1039
220 JOINT STIFFNESS 2724 0.1037
221 GAIT INABILITY 3466 0.1036
222 BACK INJURY 1114 0.1023
223 SEPTIC SHOCK 4436 0.1018
224 WHEELCHAIR USER 448 0.1007
225 PULMONARY ALVEOLAR HAEMORRHAGE 565 0.1006
226 ORAL CANDIDIASIS 1320 0.1001
227 ARTHRITIS 7849 0.0997
228 UVEITIS 1353 0.0997
229 ANAL ABSCESS 536 0.0994
230 MYOPATHY 856 0.0990
231 TUMOUR LYSIS SYNDROME 870 0.0988
232 RESPIRATORY TRACT CONGESTION 1571 0.0988
233 RESPIRATORY TRACT INFECTION 2573 0.0987
234 INTERVERTEBRAL DISC DEGENERATION 910 0.0983
235 MULTIPLE ALLERGIES 768 0.0979
236 ORGANISING PNEUMONIA 484 0.0976
237 IMMUNODEFICIENCY 1454 0.0974
238 BASAL CELL CARCINOMA 1519 0.0973
239 PERIPHERAL SWELLING 14999 0.0973
240 MUSCULOSKELETAL PAIN 5097 0.0972
241 INFECTION 14080 0.0972
242 ABSCESS LIMB 413 0.0968
243 FEBRILE NEUTROPENIA 6426 0.0968
244 BODY TEMPERATURE INCREASED 1970 0.0965
245 HAEMATOCHEZIA 5326 0.0964
246 EMPHYSEMA 973 0.0964
247 BACTERAEMIA 1141 0.0960
248 MACULAR DEGENERATION 1141 0.0954
249 CONDITION AGGRAVATED 29049 0.0954
250 HEART RATE DECREASED 3350 0.0953
251 DRUG TOLERANCE 482 0.0952
252 HYPERCALCAEMIA 1176 0.0951
253 MATERNAL EXPOSURE DURING PREGNANCY 8481 0.0951
254 SINUS CONGESTION 1281 0.0947
255 END STAGE RENAL DISEASE 1724 0.0944
256 DYSPNOEA EXERTIONAL 3558 0.0944
257 RESPIRATORY DISORDER 2818 0.0941
258 OEDEMA 5092 0.0938
259 SUSPECTED OFF LABEL USE 424 0.0938
260 HAEMATOTOXICITY 891 0.0937
261 OXYGEN SATURATION DECREASED 5265 0.0936
262 ILL-DEFINED DISORDER 5690 0.0936
263 IMPAIRED QUALITY OF LIFE 1338 0.0930
264 IRON DEFICIENCY 417 0.0926
265 REBOUND EFFECT 1043 0.0922
266 LIVER FUNCTION TEST INCREASED 1975 0.0919
267 POLYP 596 0.0909
268 FISTULA 1022 0.0908
269 ENTERITIS 580 0.0905
270 SKIN ULCER 2342 0.0905
271 NEUROLOGICAL SYMPTOM 515 0.0900
272 ABDOMINAL DISCOMFORT 15023 0.0895
273 GASTROINTESTINAL DISORDER 8004 0.0893
274 PULMONARY TOXICITY 631 0.0891
275 OSTEOPENIA 1348 0.0887
276 ACUTE RESPIRATORY FAILURE 1704 0.0885
277 PRESCRIBED OVERDOSE 1706 0.0881
278 WEIGHT FLUCTUATION 922 0.0880
279 ANAL FISTULA 470 0.0880
280 SLEEP APNOEA SYNDROME 1680 0.0879
281 INFUSION SITE EXTRAVASATION 547 0.0878
282 ULCER 1395 0.0876
283 ULCER HAEMORRHAGE 592 0.0874
284 LUNG INFILTRATION 771 0.0872
285 UPPER RESPIRATORY TRACT INFECTION 4030 0.0871
286 ABSCESS 1390 0.0870
287 BLOOD TEST ABNORMAL 1224 0.0870
288 BACTERIAL INFECTION 1625 0.0870
289 PNEUMONIA BACTERIAL 798 0.0869
290 POSTOPERATIVE WOUND INFECTION 586 0.0867
291 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4524 0.0866
292 LYMPHOPENIA 1223 0.0864
293 CROHN'S DISEASE 592 0.0863
294 BENIGN PROSTATIC HYPERPLASIA 445 0.0861
295 LUNG INFECTION 1337 0.0860
296 RASH VESICULAR 416 0.0860
297 SKIN ATROPHY 495 0.0859
298 SEASONAL ALLERGY 1210 0.0854
299 MYOSITIS 764 0.0851
300 SECRETION DISCHARGE 1063 0.0848
301 HERPES ZOSTER 4876 0.0848
302 TOOTH INFECTION 1115 0.0845
303 PRODUCT LABEL CONFUSION 492 0.0843
304 HEPATITIS B 508 0.0842
305 PROCTALGIA 542 0.0842
306 BRONCHITIS 6214 0.0839
307 SPINAL OSTEOARTHRITIS 737 0.0838
308 COLITIS 3179 0.0838
309 CONTUSION 8014 0.0832
310 NASOPHARYNGITIS 15320 0.0830
311 EAR INFECTION 2209 0.0829
312 JOINT INJURY 1770 0.0828
313 CYTOPENIA 1013 0.0827
314 ACUTE RESPIRATORY DISTRESS SYNDROME 1461 0.0825
315 ENCEPHALITIS 571 0.0825
316 CARPAL TUNNEL SYNDROME 1150 0.0820
317 MOUTH ULCERATION 1726 0.0818
318 FAECES SOFT 595 0.0817
319 GASTROINTESTINAL INFLAMMATION 640 0.0816
320 DIARRHOEA HAEMORRHAGIC 759 0.0811
321 CARDIAC MURMUR 702 0.0811
322 ARTHRALGIA 33629 0.0808
323 SKIN LACERATION 874 0.0803
324 RENAL TUBULAR NECROSIS 783 0.0797
325 WEIGHT INCREASED 17866 0.0797
326 RECTAL HAEMORRHAGE 3427 0.0797
327 SECOND PRIMARY MALIGNANCY 662 0.0795
328 NORMAL NEWBORN 430 0.0790
329 PNEUMONIA 25547 0.0788
330 MYELODYSPLASTIC SYNDROME 1141 0.0788
331 NEUTROPHIL COUNT INCREASED 807 0.0787
332 BLOOD IRON DECREASED 929 0.0782
333 LOCALISED INFECTION 1887 0.0779
334 POST PROCEDURAL INFECTION 634 0.0779
335 ARTERIOSCLEROSIS CORONARY ARTERY 515 0.0777
336 SQUAMOUS CELL CARCINOMA 730 0.0775
337 SKIN INFECTION 869 0.0774
338 THROMBOTIC MICROANGIOPATHY 754 0.0773
339 PERIPHERAL SENSORY NEUROPATHY 450 0.0769
340 PLATELET COUNT INCREASED 1003 0.0769
341 MUSCLE SPASTICITY 942 0.0766
342 HEPATIC CIRRHOSIS 1437 0.0764
343 COLECTOMY 432 0.0764
344 TENDERNESS 794 0.0761
345 TOOTH ABSCESS 773 0.0758
346 SMALL INTESTINAL OBSTRUCTION 932 0.0756
347 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2143 0.0756
348 PRESCRIBED UNDERDOSE 1505 0.0754
349 ROTATOR CUFF SYNDROME 965 0.0751
350 GASTROINTESTINAL INFECTION 669 0.0746
351 SLEEP DISORDER 5261 0.0745
352 GASTROOESOPHAGEAL REFLUX DISEASE 5994 0.0744
353 COELIAC DISEASE 728 0.0741
354 PYELONEPHRITIS 643 0.0741
355 VIRAL INFECTION 2469 0.0741
356 STAPHYLOCOCCAL INFECTION 2447 0.0741
357 OSTEOMYELITIS 1342 0.0740
358 ALOPECIA 14449 0.0735
359 NEPHROPATHY TOXIC 824 0.0733
360 NASAL CONGESTION 4312 0.0733
361 INTERSTITIAL LUNG DISEASE 3549 0.0732
362 HEPATOTOXICITY 1628 0.0730
363 BONE DISORDER 1332 0.0730
364 NEPHROTIC SYNDROME 501 0.0730
365 CYSTITIS 2326 0.0730
366 KIDNEY INFECTION 1432 0.0729
367 SINUS DISORDER 1444 0.0728
368 DEFORMITY 681 0.0728
369 UROSEPSIS 672 0.0728
370 LYMPHOMA 1124 0.0727
371 SKIN LESION 1994 0.0726
372 CATARACT 4327 0.0726
373 INCREASED TENDENCY TO BRUISE 668 0.0725
374 ACUTE MYELOID LEUKAEMIA 1129 0.0724
375 RESPIRATORY FAILURE 5276 0.0723
376 CELLULITIS 3626 0.0719
377 ECCHYMOSIS 493 0.0718
378 CONGENITAL ANOMALY 555 0.0716
379 HYDRONEPHROSIS 535 0.0714
380 CYST 885 0.0712
381 HYPERSENSITIVITY 13179 0.0709
382 PNEUMONITIS 1931 0.0708
383 PANCYTOPENIA 3953 0.0707
384 DIVERTICULITIS 1957 0.0706
385 BLOOD ALBUMIN DECREASED 560 0.0705
386 GOUT 1265 0.0704
387 PLEURISY 418 0.0703
388 FUNGAL INFECTION 2345 0.0703
389 LYMPHADENOPATHY 2487 0.0702
390 COUGH 19665 0.0701
391 BLOOD LACTATE DEHYDROGENASE INCREASED 1110 0.0700
392 INFUSION SITE SWELLING 440 0.0699
393 GENERAL PHYSICAL HEALTH DETERIORATION 8084 0.0698
394 HYPOXIA 2458 0.0697
395 TENDON DISORDER 453 0.0694
396 FLANK PAIN 651 0.0694
397 MASS 970 0.0693
398 RIB FRACTURE 1420 0.0690
399 ANKYLOSING SPONDYLITIS 907 0.0687
400 PULMONARY CONGESTION 903 0.0684
401 DISEASE RECURRENCE 3254 0.0683
402 THERAPEUTIC RESPONSE SHORTENED 2268 0.0683
403 MUCOSAL INFLAMMATION 1790 0.0683
404 HYPERTENSION 14481 0.0683
405 SPINAL COMPRESSION FRACTURE 565 0.0683
406 ORAL HERPES 1333 0.0682
407 HIATUS HERNIA 884 0.0682
408 IRON DEFICIENCY ANAEMIA 627 0.0679
409 HEPATITIS 1737 0.0678
410 HAEMOLYSIS 523 0.0677
411 WHITE BLOOD CELL COUNT ABNORMAL 432 0.0676
412 HEART RATE IRREGULAR 1529 0.0676
413 PHARYNGITIS 839 0.0676
414 INTESTINAL PERFORATION 758 0.0675
415 LEUKOPENIA 3375 0.0674
416 BREAST CANCER STAGE II 561 0.0674
417 TENDON RUPTURE 832 0.0673
418 HYPERTRANSAMINASAEMIA 468 0.0672
419 GASTROENTERITIS VIRAL 1214 0.0672
420 PROSTATIC SPECIFIC ANTIGEN INCREASED 921 0.0668
421 NECK PAIN 3731 0.0667
422 BLOOD PRESSURE INCREASED 10190 0.0666
423 TUBULOINTERSTITIAL NEPHRITIS 1245 0.0664
424 SPLENOMEGALY 778 0.0663
425 SPINAL DISORDER 628 0.0662
426 DISEASE PROGRESSION 7846 0.0662
427 RHINORRHOEA 4260 0.0658
428 IMMUNE SYSTEM DISORDER 866 0.0656
429 SKIN PLAQUE 554 0.0656
430 ARTERIOSCLEROSIS 618 0.0656
431 EOSINOPHILIA 1148 0.0654
432 INJURY 4576 0.0650
433 GASTROENTERITIS 950 0.0650
434 OROPHARYNGEAL PAIN 5999 0.0647
435 OFF LABEL USE 56495 0.0645
436 PROTEINURIA 1223 0.0643
437 FOOT FRACTURE 1219 0.0642
438 LARGE INTESTINE PERFORATION 446 0.0642
439 TASTE DISORDER 1302 0.0641
440 INFLUENZA 7142 0.0640
441 SEPSIS 7141 0.0640
442 LIGAMENT SPRAIN 631 0.0638
443 DISABILITY 1260 0.0637
444 LARGE INTESTINE POLYP 441 0.0636
445 PYREXIA 22013 0.0636
446 ROAD TRAFFIC ACCIDENT 2660 0.0635
447 SKIN MASS 424 0.0634
448 WHITE BLOOD CELL COUNT INCREASED 2435 0.0634
449 DRUG-INDUCED LIVER INJURY 1974 0.0629
450 DIVERTICULUM 446 0.0627
451 HAEMATOCRIT DECREASED 1243 0.0626
452 DYSPNOEA 35482 0.0626
453 LIVER DISORDER 2773 0.0625
454 PAIN 38346 0.0624
455 CHRONIC KIDNEY DISEASE 4736 0.0623
456 NERVE COMPRESSION 573 0.0620
457 LYMPHOEDEMA 429 0.0620
458 WEIGHT DECREASED 17302 0.0619
459 EXPOSURE DURING PREGNANCY 3849 0.0619
460 HAEMORRHOIDS 1204 0.0617
461 URTICARIA 10266 0.0612
462 RESPIRATORY SYNCYTIAL VIRUS INFECTION 533 0.0612
463 HEART RATE INCREASED 6047 0.0610
464 FEAR OF INJECTION 435 0.0609
465 CHEST DISCOMFORT 6218 0.0607
466 HAEMOPTYSIS 1693 0.0606
467 RENAL CYST 481 0.0605
468 MUSCULOSKELETAL DISORDER 1150 0.0604
469 LIMB INJURY 1641 0.0604
470 PNEUMOTHORAX 958 0.0604
471 GLAUCOMA 1161 0.0602
472 FRUSTRATION TOLERANCE DECREASED 487 0.0602
473 GINGIVAL PAIN 478 0.0600
474 EYE INFECTION 675 0.0597
475 ANAL INCONTINENCE 536 0.0595
476 TENDONITIS 922 0.0595
477 AUTOIMMUNE HEPATITIS 413 0.0593
478 INTERVERTEBRAL DISC PROTRUSION 1298 0.0593
479 NEUTROPENIC SEPSIS 422 0.0590
480 FURUNCLE 468 0.0590
481 ABDOMINAL PAIN 13720 0.0589
482 PAIN IN EXTREMITY 17373 0.0589
483 LEUKOCYTOSIS 1066 0.0588
484 HYPERGLYCAEMIA 2142 0.0587
485 NEPHROLITHIASIS 2685 0.0585
486 MUSCULOSKELETAL CHEST PAIN 906 0.0585
487 PHARYNGITIS STREPTOCOCCAL 633 0.0584
488 CYTOKINE RELEASE SYNDROME 1173 0.0584
489 HEPATIC STEATOSIS 1089 0.0584
490 THERAPEUTIC RESPONSE DECREASED 3541 0.0583
491 CARDIOMYOPATHY 862 0.0583
492 MUSCULOSKELETAL DISCOMFORT 1001 0.0581
493 TOOTH FRACTURE 641 0.0581
494 DIABETES MELLITUS 4426 0.0580
495 IMPAIRED WORK ABILITY 1238 0.0579
496 ARTHROPOD BITE 429 0.0578
497 MIDDLE INSOMNIA 1080 0.0578
498 PRODUCT USE ISSUE 10864 0.0577
499 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 991 0.0577
500 SPINAL FRACTURE 1157 0.0577
501 VITAMIN D DEFICIENCY 563 0.0577
502 FOOD ALLERGY 444 0.0575
503 PREGNANCY 1150 0.0574
504 MALNUTRITION 641 0.0572
505 OEDEMA PERIPHERAL 6961 0.0571
506 QUALITY OF LIFE DECREASED 765 0.0570
507 MUSCULAR WEAKNESS 6461 0.0568
508 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3111 0.0566
509 ORAL DISORDER 415 0.0566
510 NEPHROPATHY 528 0.0565
511 PULMONARY HAEMORRHAGE 442 0.0564
512 PELVIC FRACTURE 440 0.0564
513 BLOOD MAGNESIUM DECREASED 487 0.0564
514 INTESTINAL OBSTRUCTION 2125 0.0563
515 SENSORY LOSS 449 0.0557
516 HYPOAESTHESIA 8308 0.0555
517 PLEURAL EFFUSION 3376 0.0554
518 BOWEL MOVEMENT IRREGULARITY 422 0.0550
519 MIGRAINE 5256 0.0550
520 SPINAL PAIN 645 0.0550
521 URINARY TRACT INFECTION 9384 0.0550
522 ACUTE KIDNEY INJURY 8391 0.0548
523 COVID-19 9598 0.0547
524 APHONIA 763 0.0546
525 DELIRIUM 1895 0.0545
526 ARTERIAL OCCLUSIVE DISEASE 427 0.0543
527 INFUSION SITE PAIN 700 0.0543
528 HYPERLIPIDAEMIA 645 0.0539
529 HAEMOGLOBIN DECREASED 5534 0.0538
530 MUSCLE STRAIN 465 0.0537
531 TRICUSPID VALVE INCOMPETENCE 427 0.0537
532 SNEEZING 1205 0.0537
533 DRUG RESISTANCE 1380 0.0537
534 DYSPEPSIA 5277 0.0536
535 PRODUCT USE IN UNAPPROVED INDICATION 13253 0.0534
536 RASH 23278 0.0533
537 DRY MOUTH 4326 0.0533
538 MALIGNANT MELANOMA 714 0.0532
539 FATIGUE 41441 0.0532
540 HYPOTHYROIDISM 1693 0.0530
541 PULMONARY THROMBOSIS 576 0.0528
542 CARDIOTOXICITY 471 0.0527
543 RESPIRATORY DISTRESS 1455 0.0527
544 BACK DISORDER 857 0.0527
545 HERNIA 1019 0.0526
546 MITRAL VALVE INCOMPETENCE 596 0.0526
547 DRUG ERUPTION 933 0.0526
548 EYE INFLAMMATION 502 0.0526
549 CONFUSIONAL STATE 8486 0.0525
550 SHOCK HAEMORRHAGIC 427 0.0524
551 DEEP VEIN THROMBOSIS 3403 0.0523
552 WRIST FRACTURE 627 0.0523
553 BEDRIDDEN 686 0.0521
554 DECREASED ACTIVITY 563 0.0521
555 TOOTH DISORDER 1160 0.0521
556 NERVE INJURY 579 0.0520
557 VITAMIN D DECREASED 445 0.0520
558 BLOOD POTASSIUM DECREASED 1559 0.0518
559 THROMBOCYTOPENIA 5792 0.0517
560 OESOPHAGITIS 563 0.0515
561 NEUROTOXICITY 902 0.0514
562 GAIT DISTURBANCE 9796 0.0511
563 CARDIOMEGALY 628 0.0510
564 DRUG INEFFECTIVE 67276 0.0510
565 PERICARDIAL EFFUSION 1180 0.0510
566 PHARYNGEAL SWELLING 499 0.0509
567 CHEST PAIN 9444 0.0509
568 GASTRIC ULCER 967 0.0508
569 BONE MARROW FAILURE 1032 0.0507
570 LYMPHOCYTE COUNT DECREASED 895 0.0506
571 POLYNEUROPATHY 601 0.0501
572 ABNORMAL FAECES 411 0.0501
573 NEURALGIA 1218 0.0500
574 ADVERSE REACTION 664 0.0500
575 ACUTE HEPATIC FAILURE 684 0.0500
576 THYROID DISORDER 771 0.0500
577 RASH PRURITIC 2703 0.0498
578 GENERALISED OEDEMA 617 0.0498
579 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8960 0.0497
580 THROAT IRRITATION 2228 0.0496
581 ANAEMIA 9469 0.0496
582 ASTHENIA 18640 0.0495
583 BLOOD CREATININE INCREASED 3230 0.0494
584 PULMONARY EMBOLISM 4697 0.0494
585 ANKLE FRACTURE 763 0.0492
586 HAEMOLYTIC ANAEMIA 439 0.0490
587 NEUTROPENIA 6650 0.0489
588 BACK PAIN 11352 0.0488
589 FLUID RETENTION 2477 0.0486
590 LOCAL SWELLING 848 0.0486
591 PULMONARY HYPERTENSION 1009 0.0484
592 MALAISE 21186 0.0483
593 PARAESTHESIA ORAL 696 0.0482
594 RENAL FAILURE 6368 0.0479
595 DYSPHONIA 2792 0.0477
596 HYPOKALAEMIA 2202 0.0477
597 EAR DISCOMFORT 489 0.0476
598 LIMB DISCOMFORT 1470 0.0475
599 PATHOGEN RESISTANCE 433 0.0475
600 OSTEONECROSIS 1555 0.0473
601 DENTAL CARIES 523 0.0472
602 INFLAMMATORY BOWEL DISEASE 462 0.0472
603 POOR QUALITY SLEEP 1014 0.0471
604 PETECHIAE 491 0.0470
605 SWELLING FACE 3051 0.0468
606 SARS-COV-2 TEST POSITIVE 618 0.0467
607 SCRATCH 492 0.0466
608 ATRIAL FIBRILLATION 4527 0.0464
609 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1360 0.0464
610 ABDOMINAL PAIN UPPER 9544 0.0463
611 PAIN IN JAW 1309 0.0462
612 HYPERBILIRUBINAEMIA 478 0.0461
613 POST PROCEDURAL COMPLICATION 886 0.0461
614 DRUG LEVEL INCREASED 762 0.0460
615 BLOOD URINE PRESENT 873 0.0459
616 PHOTOSENSITIVITY REACTION 755 0.0457
617 ALANINE AMINOTRANSFERASE INCREASED 2800 0.0456
618 ENCEPHALOPATHY 1116 0.0454
619 ABDOMINAL DISTENSION 4726 0.0452
620 RED BLOOD CELL COUNT DECREASED 1293 0.0452
621 NEUROPATHY PERIPHERAL 4270 0.0448
622 DIARRHOEA 28903 0.0447
623 LACERATION 419 0.0445
624 TRANSAMINASES INCREASED 989 0.0444
625 GASTROINTESTINAL PAIN 489 0.0444
626 UPPER LIMB FRACTURE 885 0.0444
627 DECREASED APPETITE 10291 0.0443
628 ORAL PAIN 992 0.0443
629 PREMATURE DELIVERY 705 0.0442
630 HYPOKINESIA 640 0.0440
631 CONJUNCTIVITIS 817 0.0440
632 BODY HEIGHT DECREASED 466 0.0435
633 MYOCARDITIS 498 0.0434
634 CHILLS 5089 0.0434
635 MOTOR DYSFUNCTION 442 0.0433
636 SCAR 741 0.0432
637 ILLNESS 4455 0.0432
638 PULMONARY OEDEMA 1934 0.0431
639 EJECTION FRACTION DECREASED 671 0.0431
640 HEADACHE 27056 0.0431
641 INSOMNIA 11469 0.0430
642 MUSCLE ATROPHY 545 0.0430
643 GLOMERULAR FILTRATION RATE DECREASED 528 0.0429
644 DEVICE RELATED INFECTION 661 0.0429
645 EATING DISORDER 914 0.0429
646 SKIN HAEMORRHAGE 636 0.0429
647 ASPARTATE AMINOTRANSFERASE INCREASED 2278 0.0428
648 DYSSTASIA 1251 0.0428
649 TOOTHACHE 775 0.0428
650 EPILEPSY 1308 0.0427
651 DERMATITIS ALLERGIC 538 0.0427
652 ANAPHYLACTIC REACTION 2354 0.0426
653 MICTURITION URGENCY 484 0.0423
654 HYPOPHAGIA 1083 0.0423
655 SCAB 483 0.0423
656 GASTRITIS 1112 0.0422
657 SKIN DISORDER 1406 0.0421
658 THROMBOSIS 3388 0.0421
659 HEPATOMEGALY 413 0.0420
660 HEMIPARESIS 711 0.0419
661 BLOOD PRESSURE ABNORMAL 833 0.0419
662 RENAL IMPAIRMENT 3502 0.0416
663 EYE DISORDER 1368 0.0416
664 MENTAL STATUS CHANGES 1153 0.0415
665 VOMITING 19509 0.0415
666 GASTRIC DISORDER 1423 0.0414
667 DERMATITIS CONTACT 472 0.0413
668 PARAESTHESIA 6464 0.0410
669 NEOPLASM 472 0.0410
670 PANCREATITIS 2151 0.0407
671 GALLBLADDER DISORDER 726 0.0406
672 HAEMATURIA 1390 0.0405
673 BRONCHOSPASM 579 0.0405
674 PNEUMONIA ASPIRATION 1013 0.0405
675 FEMUR FRACTURE 1251 0.0404
676 MULTI-ORGAN FAILURE 694 0.0401
677 BLOOD UREA INCREASED 672 0.0401
678 PRURITUS 15373 0.0400
679 PREMATURE BABY 1201 0.0399
680 DERMATITIS 835 0.0398
681 RENAL DISORDER 1852 0.0397
682 THROAT TIGHTNESS 1074 0.0397
683 INJECTION SITE EXTRAVASATION 488 0.0395
684 CHOLELITHIASIS 1293 0.0394
685 MOVEMENT DISORDER 1264 0.0393
686 SWOLLEN TONGUE 1229 0.0393
687 SKIN CANCER 846 0.0393
688 ELECTROLYTE IMBALANCE 456 0.0392
689 DEHYDRATION 5230 0.0392
690 FEELING HOT 2402 0.0391
691 AGRANULOCYTOSIS 727 0.0391
692 FEELING COLD 1083 0.0389
693 ASPIRATION 425 0.0388
694 DRUG EFFECT INCOMPLETE 1407 0.0387
695 HYPOCALCAEMIA 732 0.0386
696 DRY EYE 1923 0.0385
697 LACRIMATION INCREASED 1162 0.0384
698 DYSURIA 1414 0.0384
699 TOOTH EXTRACTION 478 0.0384
700 FALL 12779 0.0384
701 BONE PAIN 2244 0.0383
702 BLINDNESS UNILATERAL 539 0.0382
703 SINUS TACHYCARDIA 542 0.0381
704 ADVERSE DRUG REACTION 3425 0.0381
705 COAGULOPATHY 632 0.0379
706 BLOOD PRESSURE DECREASED 2517 0.0378
707 MUSCLE SPASMS 6934 0.0377
708 PHOTOPHOBIA 710 0.0377
709 RENAL INJURY 1121 0.0377
710 BONE DENSITY DECREASED 1182 0.0377
711 DISSEMINATED INTRAVASCULAR COAGULATION 531 0.0377
712 PLATELET COUNT DECREASED 4008 0.0376
713 ANGINA PECTORIS 1074 0.0374
714 DEPRESSION 8507 0.0374
715 HYPOTENSION 7484 0.0373
716 HEAD DISCOMFORT 659 0.0372
717 TACHYCARDIA 3302 0.0371
718 HIP FRACTURE 1191 0.0370
719 LABORATORY TEST ABNORMAL 1089 0.0369
720 PROCEDURAL PAIN 1018 0.0367
721 HAEMATOMA 950 0.0366
722 LIVER FUNCTION TEST ABNORMAL 1066 0.0366
723 NAUSEA 28987 0.0366
724 TACHYPNOEA 495 0.0364
725 INFLUENZA LIKE ILLNESS 2988 0.0363
726 DIPLOPIA 941 0.0362
727 SKIN DISCOLOURATION 1664 0.0362
728 CHOLECYSTITIS 431 0.0361
729 DYSPHAGIA 3434 0.0361
730 CARDIAC FAILURE CONGESTIVE 2906 0.0361
731 INJECTION SITE REACTION 2488 0.0361
732 ADVERSE EVENT 3331 0.0361
733 BLOOD SODIUM DECREASED 677 0.0359
734 BLOOD ALKALINE PHOSPHATASE INCREASED 889 0.0358
735 FLUID OVERLOAD 520 0.0357
736 HYPOAESTHESIA ORAL 538 0.0357
737 ECONOMIC PROBLEM 540 0.0356
738 POLLAKIURIA 1486 0.0356
739 BLOOD BILIRUBIN INCREASED 962 0.0356
740 ILEUS 441 0.0355
741 CORONARY ARTERY OCCLUSION 486 0.0354
742 RASH MACULAR 1236 0.0353
743 PSORIASIS 4616 0.0353
744 FEEDING DISORDER 715 0.0352
745 AMNESIA 2293 0.0352
746 EYE SWELLING 1310 0.0352
747 ANXIETY 10014 0.0352
748 SPINAL OPERATION 433 0.0351
749 MULTIPLE FRACTURES 577 0.0351
750 BLOOD POTASSIUM INCREASED 570 0.0351
751 BRAIN OEDEMA 442 0.0350
752 INTENTIONAL DOSE OMISSION 995 0.0349
753 MEMORY IMPAIRMENT 4787 0.0348
754 ASCITES 1024 0.0348
755 HYPERKALAEMIA 1218 0.0347
756 INCREASED APPETITE 663 0.0347
757 INTRAOCULAR PRESSURE INCREASED 441 0.0345
758 HYPERTHYROIDISM 498 0.0344
759 BURNING SENSATION 2403 0.0342
760 INJECTION SITE BRUISING 2720 0.0341
761 ABDOMINAL PAIN LOWER 861 0.0340
762 ERYTHEMA 6994 0.0340
763 MYALGIA 5783 0.0340
764 NOCTURIA 412 0.0339
765 RASH MACULO-PAPULAR 753 0.0338
766 FRACTURE 638 0.0337
767 DRUG INTERACTION 5346 0.0337
768 GINGIVAL BLEEDING 460 0.0337
769 RASH ERYTHEMATOUS 1610 0.0336
770 CARDIOGENIC SHOCK 482 0.0336
771 PALLOR 906 0.0333
772 PERIPHERAL COLDNESS 456 0.0332
773 EPISTAXIS 2483 0.0332
774 DIZZINESS 16522 0.0331
775 HYPOMAGNESAEMIA 460 0.0330
776 FAECES DISCOLOURED 715 0.0329
777 HOT FLUSH 2478 0.0328
778 FLATULENCE 1858 0.0327
779 ACUTE MYOCARDIAL INFARCTION 965 0.0327
780 ECZEMA 1704 0.0325
781 METASTASES TO BONE 532 0.0324
782 CORONARY ARTERY DISEASE 978 0.0323
783 BLINDNESS 1316 0.0323
784 EYE PRURITUS 1076 0.0320
785 EYE PAIN 1805 0.0320
786 PANCREATITIS ACUTE 718 0.0319
787 UPPER GASTROINTESTINAL HAEMORRHAGE 537 0.0319
788 DIABETES MELLITUS INADEQUATE CONTROL 563 0.0318
789 BRAIN FOG 497 0.0317
790 DEAFNESS 829 0.0317
791 EYE HAEMORRHAGE 423 0.0317
792 VISUAL IMPAIRMENT 3925 0.0316
793 COORDINATION ABNORMAL 441 0.0316
794 GASTROINTESTINAL HAEMORRHAGE 2632 0.0315
795 PLASMA CELL MYELOMA 1228 0.0314
796 PRESYNCOPE 765 0.0314
797 INSURANCE ISSUE 481 0.0314
798 PULMONARY ARTERIAL HYPERTENSION 455 0.0314
799 PHARYNGEAL OEDEMA 482 0.0313
800 HYPERSOMNIA 895 0.0312
801 CARDIAC FAILURE 2502 0.0311
802 SKIN REACTION 439 0.0311
803 IMPAIRED GASTRIC EMPTYING 424 0.0311
804 WHITE BLOOD CELL COUNT DECREASED 3359 0.0310
805 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 797 0.0309
806 URINARY INCONTINENCE 916 0.0309
807 DRUG EFFECT DECREASED 1662 0.0308
808 CARDIAC DISORDER 2881 0.0308
809 LIP SWELLING 1025 0.0307
810 TINNITUS 1410 0.0307
811 INJECTION SITE RASH 941 0.0306
812 CONSTIPATION 6675 0.0306
813 FEELING JITTERY 581 0.0305
814 NEOPLASM PROGRESSION 1060 0.0305
815 TOXIC EPIDERMAL NECROLYSIS 462 0.0304
816 PALPITATIONS 3558 0.0303
817 HEPATIC FAILURE 914 0.0303
818 VERTIGO 1836 0.0301
819 RENAL FAILURE ACUTE 1278 0.0301
820 RASH PAPULAR 675 0.0301
821 TRANSIENT ISCHAEMIC ATTACK 1008 0.0298
822 ORAL DISCOMFORT 415 0.0298
823 SHOCK 685 0.0298
824 HYPERHIDROSIS 3825 0.0297
825 ANHEDONIA 780 0.0297
826 SYNCOPE 2957 0.0295
827 OSTEONECROSIS OF JAW 731 0.0295
828 HOSPITALISATION 4529 0.0294
829 MUSCLE TIGHTNESS 476 0.0294
830 ABASIA 722 0.0292
831 HAEMORRHAGE 3054 0.0292
832 HYPOACUSIS 1257 0.0292
833 OCULAR HYPERAEMIA 1385 0.0292
834 HEAD INJURY 922 0.0291
835 VENTRICULAR TACHYCARDIA 479 0.0290
836 NEUTROPHIL COUNT DECREASED 1180 0.0289
837 INJECTION SITE PRURITUS 1939 0.0289
838 APHASIA 873 0.0289
839 NERVOUS SYSTEM DISORDER 893 0.0286
840 CHOKING 557 0.0285
841 VISION BLURRED 3903 0.0284
842 FEELING ABNORMAL 6804 0.0284
843 SURGERY 1663 0.0283
844 NERVOUSNESS 1482 0.0283
845 PRODUCT DOSE OMISSION IN ERROR 800 0.0282
846 MEDICATION ERROR 1568 0.0282
847 DYSARTHRIA 1059 0.0281
848 HYPONATRAEMIA 1584 0.0281
849 ANGIOEDEMA 1243 0.0281
850 BLOOD TRIGLYCERIDES INCREASED 495 0.0280
851 BLOOD GLUCOSE ABNORMAL 514 0.0278
852 TREMOR 4615 0.0278
853 LETHARGY 1585 0.0275
854 RETCHING 585 0.0274
855 PERITONITIS 567 0.0273
856 TREATMENT NONCOMPLIANCE 1497 0.0273
857 JAUNDICE 736 0.0273
858 BALANCE DISORDER 2349 0.0271
859 UNDERDOSE 1978 0.0271
860 METABOLIC ACIDOSIS 865 0.0270
861 RESTLESS LEGS SYNDROME 483 0.0265
862 CHOLESTASIS 508 0.0264
863 ISCHAEMIC STROKE 472 0.0264
864 MYELOSUPPRESSION 952 0.0264
865 DEPRESSED MOOD 1395 0.0264
866 URINARY RETENTION 879 0.0263
867 LUNG NEOPLASM MALIGNANT 1080 0.0262
868 ACTIVITIES OF DAILY LIVING IMPAIRED 519 0.0262
869 GAMMA-GLUTAMYLTRANSFERASE INCREASED 575 0.0259
870 UNEVALUABLE EVENT 1963 0.0259
871 CHROMATURIA 583 0.0258
872 ARRHYTHMIA 1218 0.0257
873 MELAENA 566 0.0257
874 INJECTION SITE WARMTH 524 0.0254
875 FACE OEDEMA 429 0.0254
876 SPEECH DISORDER 1319 0.0251
877 PRURITUS GENERALISED 543 0.0251
878 INJECTION SITE ERYTHEMA 3114 0.0251
879 PRODUCT AVAILABILITY ISSUE 571 0.0251
880 INJECTION SITE URTICARIA 609 0.0248
881 FULL BLOOD COUNT DECREASED 500 0.0248
882 MALIGNANT NEOPLASM PROGRESSION 2540 0.0248
883 AGEUSIA 618 0.0247
884 INTERNATIONAL NORMALISED RATIO INCREASED 705 0.0247
885 LOSS OF CONSCIOUSNESS 3152 0.0246
886 CARDIAC ARREST 2012 0.0243
887 INJECTION SITE PAIN 7474 0.0243
888 NEOPLASM MALIGNANT 1620 0.0242
889 PSYCHOTIC DISORDER 713 0.0241
890 BLOOD GLUCOSE INCREASED 4529 0.0240
891 PRODUCT DOSE OMISSION ISSUE 7063 0.0240
892 SOMNOLENCE 4836 0.0240
893 PRODUCT PRESCRIBING ISSUE 522 0.0239
894 FOETAL EXPOSURE DURING PREGNANCY 1941 0.0239
895 THIRST 426 0.0238
896 FLUSHING 2407 0.0237
897 INJECTION SITE SWELLING 1812 0.0236
898 RASH GENERALISED 609 0.0235
899 HAEMATEMESIS 595 0.0234
900 COMA 1117 0.0234
901 COLD SWEAT 413 0.0234
902 THERAPY INTERRUPTED 1653 0.0231
903 PANIC ATTACK 841 0.0231
904 SKIN EXFOLIATION 1927 0.0228
905 MENTAL DISORDER 989 0.0227
906 PAIN OF SKIN 610 0.0226
907 VISUAL ACUITY REDUCED 744 0.0224
908 PRODUCT DOSE OMISSION 1460 0.0223
909 INJECTION SITE HAEMORRHAGE 1783 0.0223
910 THERAPEUTIC RESPONSE UNEXPECTED 999 0.0222
911 DISORIENTATION 882 0.0222
912 CRYING 804 0.0221
913 TOXICITY TO VARIOUS AGENTS 3723 0.0221
914 SKIN FISSURES 431 0.0220
915 INCORRECT DOSE ADMINISTERED 5027 0.0220
916 MYOCARDIAL INFARCTION 3800 0.0218
917 CEREBROVASCULAR ACCIDENT 3635 0.0214
918 ANAPHYLACTIC SHOCK 548 0.0212
919 MOOD SWINGS 677 0.0212
920 TOOTH LOSS 438 0.0211
921 ABORTION SPONTANEOUS 843 0.0210
922 PRODUCT PRESCRIBING ERROR 501 0.0210
923 THERAPY CESSATION 1068 0.0208
924 ACNE 1567 0.0206
925 MUSCLE TWITCHING 476 0.0206
926 DIABETIC KETOACIDOSIS 486 0.0202
927 DYSGEUSIA 1499 0.0202
928 COGNITIVE DISORDER 938 0.0201
929 BLOOD CREATINE PHOSPHOKINASE INCREASED 578 0.0201
930 UNRESPONSIVE TO STIMULI 517 0.0200
931 FEAR 535 0.0199
932 CARDIOVASCULAR DISORDER 496 0.0195
933 SEIZURE 2245 0.0194
934 EMOTIONAL DISORDER 596 0.0193
935 CEREBRAL HAEMORRHAGE 681 0.0190
936 STEVENS-JOHNSON SYNDROME 421 0.0189
937 LACTIC ACIDOSIS 604 0.0186
938 DEMENTIA 521 0.0186
939 DRUG DOSE OMISSION 3011 0.0182
940 AGITATION 1337 0.0182
941 WRONG TECHNIQUE IN DRUG USAGE PROCESS 661 0.0182
942 BLOOD GLUCOSE DECREASED 869 0.0181
943 MOOD ALTERED 493 0.0181
944 INTENTIONAL PRODUCT MISUSE 1578 0.0180
945 EYE IRRITATION 1036 0.0180
946 GLYCOSYLATED HAEMOGLOBIN INCREASED 454 0.0180
947 RHABDOMYOLYSIS 740 0.0177
948 MENTAL IMPAIRMENT 423 0.0174
949 HYPOGLYCAEMIA 842 0.0173
950 DERMATITIS ATOPIC 914 0.0173
951 RESTLESSNESS 632 0.0173
952 CEREBRAL INFARCTION 418 0.0171
953 CARDIO-RESPIRATORY ARREST 713 0.0170
954 IRRITABILITY 1023 0.0170
955 DEVICE MALFUNCTION 1192 0.0169
956 NEEDLE ISSUE 492 0.0169
957 HALLUCINATION 1260 0.0167
958 DISTURBANCE IN ATTENTION 894 0.0166
959 INJECTION SITE MASS 612 0.0165
960 DEATH 14224 0.0165
961 HEPATIC FUNCTION ABNORMAL 616 0.0165
962 DRY SKIN 2177 0.0163
963 RESPIRATORY ARREST 446 0.0162
964 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1124 0.0158
965 NIGHTMARE 546 0.0158
966 BRADYCARDIA 824 0.0155
967 ANGER 510 0.0151
968 PRODUCT QUALITY ISSUE 2029 0.0149
969 ACCIDENTAL OVERDOSE 542 0.0148
970 EMOTIONAL DISTRESS 1783 0.0147
971 MULTIPLE SCLEROSIS 704 0.0147
972 DEVICE ISSUE 1254 0.0140
973 DEPRESSED LEVEL OF CONSCIOUSNESS 539 0.0136
974 CONVULSION 766 0.0134
975 SUICIDAL IDEATION 1226 0.0134
976 DYSKINESIA 543 0.0133
977 MULTIPLE SCLEROSIS RELAPSE 905 0.0132
978 ELECTROCARDIOGRAM QT PROLONGED 458 0.0127
979 NO ADVERSE EVENT 2285 0.0126
980 PROSTATE CANCER 1009 0.0125
981 ABNORMAL BEHAVIOUR 471 0.0119
982 OVERDOSE 2355 0.0109
983 SKIN IRRITATION 494 0.0108
984 AGGRESSION 531 0.0106
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2046 0.0101
986 BREAST CANCER 893 0.0096
987 SKIN BURNING SENSATION 616 0.0086
988 DRUG DEPENDENCE 1371 0.0085
989 SUICIDE ATTEMPT 498 0.0082
990 ACCIDENTAL EXPOSURE TO PRODUCT 782 0.0076
991 PRODUCT STORAGE ERROR 591 0.0067